You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Boehringer Ingelheim
Moodys
Baxter
AstraZeneca
Express Scripts

Last Updated: September 23, 2020

DrugPatentWatch Database Preview

VALPROIC ACID Drug Profile

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

When do Valproic Acid patents expire, and when can generic versions of Valproic Acid launch?

Valproic Acid is a drug marketed by Bionpharma Inc, Catalent, Novelgenix Theraps, Par Pharm, Scherer Rp, Sun Pharm Inds Ltd, Upsher Smith Labs, Ani Pharms Inc, Apotex, Eci Pharms Llc, High Tech Pharma, Lannett Co Inc, Pharm Assoc, Vistapharm, and Wockhardt Bio Ag. and is included in fifteen NDAs.

The generic ingredient in VALPROIC ACID is valproic acid. There are seventeen drug master file entries for this compound. Seventeen suppliers are listed for this compound. Additional details are available on the valproic acid profile page.

US ANDA Litigation and Generic Entry Outlook for Valproic Acid

A generic version of VALPROIC ACID was approved as valproic acid by WOCKHARDT BIO AG on July 1st, 1986.

  Start Trial

Drug patent expirations by year for VALPROIC ACID
Drug Prices for VALPROIC ACID

See drug prices for VALPROIC ACID

Recent Clinical Trials for VALPROIC ACID

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Clinipace WorldwidePhase 2
WestatPhase 2
Acrotech BiopharmaPhase 1

See all VALPROIC ACID clinical trials

Medical Subject Heading (MeSH) Categories for VALPROIC ACID

US Patents and Regulatory Information for VALPROIC ACID

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Bionpharma Inc VALPROIC ACID valproic acid CAPSULE;ORAL 073484-001 Jun 29, 1993 AB RX No Yes   Start Trial   Start Trial   Start Trial
Upsher Smith Labs VALPROIC ACID valproic acid CAPSULE;ORAL 070631-001 Jun 11, 1987 DISCN No No   Start Trial   Start Trial   Start Trial
Par Pharm VALPROIC ACID valproic acid CAPSULE;ORAL 070431-001 Feb 28, 1986 DISCN No No   Start Trial   Start Trial   Start Trial
Lannett Co Inc VALPROIC ACID valproic acid SYRUP;ORAL 077960-001 Oct 13, 2006 AA RX No No   Start Trial   Start Trial   Start Trial
Ani Pharms Inc VALPROIC ACID valproic acid SYRUP;ORAL 073178-001 Aug 25, 1992 DISCN No No   Start Trial   Start Trial   Start Trial
Vistapharm VALPROIC ACID valproic acid SYRUP;ORAL 075782-001 Dec 22, 2000 AA RX No No   Start Trial   Start Trial   Start Trial
Catalent VALPROIC ACID valproic acid CAPSULE;ORAL 073229-001 Oct 29, 1991 AB RX No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Colorcon
McKesson
Merck
Dow
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.